Pancoast tumor secondary prevention

Pancoast tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pancoast tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pancoast tumor secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pancoast tumor secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pancoast tumor secondary prevention
CDC onPancoast tumor secondary prevention
Pancoast tumor secondary prevention in the news
Blogs on Pancoast tumor secondary prevention
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Pancoast tumor secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overview

Pancoast tumor is a subtype of lung cancer localized to the lung apex. Secondary prevention for lung cancer consists of smoking cessation and screening. Secondary chemoprevention focuses on blocking the development of lung cancer in individuals in whom a precancerous lesion has been detected.

Secondary Prevention

• Pancoast tumor is a subtype of lung cancer localized to the lung apex.Secondary prevention for lung cancer consists of smoking cessation and screening.
• To view the screening of lung cancer, click here.
• Secondary chemoprevention focuses on blocking the development of lung cancer in individuals in whom a precancerous lesion has been detected. It still remains experimental.